3rd Feb 2006 10:37
Skyepharma PLC03 February 2006 For Immediate Release 3 February 2006 SkyePharma PLC ("the Company") Notification of Interests of Directors On 2 February 2006 the Executive Directors shown in the table below wereallocated ordinary shares in the Company under the SkyePharma PLC Deferred ShareBonus Plan (the "Plan") approved by shareholders at the Company's Annual GeneralMeeting held on 6th June 2001. Under the rules of the Plan the Executive Directors have invested 50% of theirbonus (after the deduction of tax) relating to the year 2005 in ordinary sharesof the Company (the "Executive Shares") at a price per share of 44 pence (thethree day average prior to 2 February 2006). Michael Ashton 73,750Donald Nicholson 41,903 In addition, the Plan provides for the Company to allocate one ordinary share at44 pence per share (the "Matching Shares"), subject to certain conditions, forevery Executive Share that would have been purchased if the gross bonus had beeninvested in shares. This allocation is subject to the following conditions: • The retention of the Executive Shares for three years from the date of acquisition • The continuous employment of the Executive throughout the three year period • The Company's comparative Total Shareholder Return performance over the three year period In respect of the following Executive Directors the number of Matching Shares towhich those Executive Directors are conditionally entitled is: Michael Ashton 125,000Donald Nicholson 71,022 END This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L